Literature DB >> 1356915

In vivo inhibition by a monoclonal antibody to CD4+ T cells of humoral and cellular immunity in sheep.

H S Gill1, D L Watson, M R Brandon.   

Abstract

The ability of intravenously injected anti-CD4 and anti-CD8 monoclonal antibody (mAb) to deplete specific lymphocyte subsets in vivo and their effects on antibody responses to ovalbumin (OVA) and Brucella abortus, and skin reactivity to T-cell mitogens was examined in merino lambs. Repeated administration of anti-CD4 or anti-CD8 mAb caused a specific and sustained depletion of target cells from peripheral blood. Anti-CD4 mAb significantly inhibited the in vivo antibody response to OVA but had no effect on the antibody response to LPS of B. abortus. In contrast, antibody responses to both OVA and B. abortus lipopolysaccharides (LPS) remained unaffected in lambs depleted of their CD8+ T lymphocytes. These results confirm the T-cell dependence and independence of antibody responses to OVA and LPS, respectively. Skin reactions elicited by intradermal injections of phytohaemagglutinin (PHA) and concanavalin A (Con A) were also significantly suppressed in lambs depleted of their CD4+ T cells, but treatment with anti-CD8 mAb had no effect on skin responsiveness. Together, these results suggest that mAb can be extremely effective at selectively depleting lymphocyte subsets in vivo and can be used for studying various aspects of immunoregulation and immunity in sheep.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356915      PMCID: PMC1421587     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.

Authors:  S P Cobbold; A Jayasuriya; A Nash; T D Prospero; H Waldmann
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

2.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

Review 3.  T cell subsets and the recognition of MHC class.

Authors:  S L Swain
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

4.  Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guérin in mice. Assessment by elimination of T cell subsets in vivo.

Authors:  T Pedrazzini; K Hug; J A Louis
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

5.  In vivo depletion of BoT4 (CD4) and of non-T4/T8 lymphocyte subsets in cattle with monoclonal antibodies.

Authors:  C J Howard; P Sopp; K R Parsons; J Finch
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

6.  Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma.

Authors:  H F Sears; D Herlyn; Z Steplewski; H Koprowski
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

7.  Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma.

Authors:  R A Miller; A R Oseroff; P T Stratte; R Levy
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

8.  Murine anti-swine T4 and T8 monoclonal antibodies: distribution and effects on proliferative and cytotoxic T cells.

Authors:  M D Pescovitz; J K Lunney; D H Sachs
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

9.  In vivo suppression of T-dependent antibody responses by treatment with a monoclonal anti-L3T4 antibody.

Authors:  P G Coulie; J P Coutelier; C Uyttenhove; P Lambotte; J Van Snick
Journal:  Eur J Immunol       Date:  1985-06       Impact factor: 5.532

10.  Role of CD4+ T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection.

Authors:  C Nauciel
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

View more
  4 in total

1.  Immunomodulatory effects of anti-CD4 antibody in host resistance against infections and tumors in human CD4 transgenic mice.

Authors:  D J Herzyk; E R Gore; R Polsky; K L Nadwodny; C C Maier; S Liu; T K Hart; A G Harmsen; P J Bugelski
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 2.  Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.

Authors:  N Chirmule; S Pahwa
Journal:  Microbiol Rev       Date:  1996-06

3.  Monoclonal antibody to CD4+ T cells abrogates genetic resistance to Haemonchus contortus in sheep.

Authors:  H S Gill; D L Watson; M R Brandon
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

4.  Estimating Loss of Brucella Abortus Antibodies from Age-Specific Serological Data In Elk.

Authors:  J A Benavides; D Caillaud; B M Scurlock; E J Maichak; W H Edwards; P C Cross
Journal:  Ecohealth       Date:  2017-05-15       Impact factor: 3.184

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.